RapidAI
Healthcare Software · Colorado, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
1120 Washington Ave Ste 200, Golden, Col...Phone Number
(650) 388-9767Website
www.rapidai.comRevenue
$47.3 MillionIndustry
ZI Rank: 3
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
4
2
2
2
2
3
About RapidAI
RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes.Explore more
RapidAI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RapidAI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if RapidAI has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once RapidAI has new funding data
Click to see if RapidAI had a recent Job posting/layoffs
Earning: See what the market has to say on RapidAI recently announced quarterly report
RapidAI, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at RapidAI
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when RapidAI launches new products
Website visits: Recent activity has been detected on your website
Check out if RapidAI is spiking on competitors!
Recommended Actions
Find VP level buyers at RapidAI
Find more new buyers
Compare Similar Companies to RapidAI
Compare insights from companies similar to RapidAI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RapidAI is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
RapidAI is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about RapidAI.
RapidAI financials insights
Gather financial insights about RapidAI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
Series B
$25M
2023
Series C
$75M
2026
Debt
$25M
RapidAI Tech Stack
A closer look at the technologies used by RapidAI
Most Recent Scoops
Funding
Funding
Person-Based
Partnership, Clinical Systems, Software, Artificial Intelligence, Healthcare Operations
Person-Based
Artificial Intelligence, Clinical Operations
Open Position
Open Position
RapidAI News & Media
New Study Finds RapidAI Significantly Outperforms Viz.ai in Detecting Medium Vessel Occlusions in Stroke Patients
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the gold standard and global leader in neurovascular AI-based clinical decision support and enterprise radiology solutions, today announced new study findings that underscore its continued leadership in stroke imaging. The findings emphasize that not all AI is created equal, with results showing that RapidAI’s clinically deep algorithms deliver superior accuracy in detecting medium vessel occlusions (MeVOs) compared to Viz.ai. The data, presented asLargest Real-World Study of Its Kind Highlights How RapidAI Aids in Identifying Challenging Aneurysms
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the gold standard in neurovascular AI-based clinical decision support and a leader in enterprise radiology solutions, today announced pivotal results from the most extensive real-world study to date on AI for aneurysm detection. Presented at the 2025 American Association of Neurological Surgeons (AANS) Annual Meeting, the retrospective, single-center study analyzed 11,694 consecutive CTA scans1, demonstrating how RapidAI’s clinically validated platfoRapidAI Reveals Superiority Over Competition in LVO Detection – 33% More Cases Identified Than Leading Competitor, Alongside Numerous Abstracts at ISC 2025
SAN MATEO, Calif.--(BUSINESS WIRE)--The numbers speak for themselves, RapidAI’s deep clinical AI is delivering results where competitors are falling short. New data from the largest head-to-head study to date proves RapidAI’s LVO detection outperforms Viz.ai by a staggering 33%, detecting far more stroke cases and reducing the risk of missed diagnoses. These findings, along with 17 influential studies, will be showcased at the American Heart Association’s International Stroke Conference (ISC) iRapidAI Secures FDA 510(k) Clearance for Groundbreaking AI 3D Head and Neck CTA Imaging: Lumina 3D™
SAN MATEO, Calif.--(BUSINESS WIRE)--RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first, automated 3D imaging reconstruction solution designed to replace manual workflows with an AI-powered approach based on the latest groundbreaking AI technology advances. “Obtaining high-quality 3D images within minutes of a CTA scan marks a significant advancement and milestone in neuroradiology,”
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RapidAI
Sign Up For FreeTo access detailed company insights
RapidAI is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes.... Read More
